Correlation of fibrinogen‑like protein 2 with disease progression in patients with severe acute pancreatitis

Ye,Xiaohua; Huai,Jiaping; Chen,Renpin; Ding,Jin; Chen,Yanping; Cai,Zhenzhai

doi:10.3892/etm.2013.1354

2014-January Volume 7 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-January Volume 7 Issue 1

Full Size Image

Article

Correlation of fibrinogen‑like protein 2 with disease progression in patients with severe acute pancreatitis

Authors:
- Xiaohua Ye
- Jiaping Huai
- Renpin Chen
- Jin Ding
- Yanping Chen
- Zhenzhai Cai
View Affiliations / Copyright

Affiliations: Department of Gastroenterology and Hepatology, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, Zhejiang 321000, P.R. China, Department of Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, Zhejiang 321000, P.R. China, Department of Gastroenterology and Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China, Department of Gastroenterology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China
Pages: 85-89
|
Published online on: October 22, 2013

https://doi.org/10.3892/etm.2013.1354
Expand metrics +

Abstract

It has recently been demonstrated that fibrinogen‑like protein 2 (fgl2) is expressed on the surface of macrophages, T cells and endothelial cells and directly cleaves prothrombin to thrombin. The present study was designed to examine fgl2 expression in patients with severe acute pancreatitis (SAP) and its correlation with disease progression. Peripheral blood mononuclear cells (PBMCs) were isolated from 25 patients with SAP, 37 patients with mild acute pancreatitis (MAP) and 20 healthy volunteers as controls. Paraffin sections of pancreas were obtained from 18 postoperative patients with SAP between 2003 and 2012. Human fgl2 (hfgl2) gene expression was determined in the PBMCs by real‑time PCR. A monoclonal antibody against hfgl2 was applied to detect hfgl2 protein expression in the pancreatic tissues as well as in the PBMCs by immunohistochemical staining. The levels of hfgl2 expression in the PBMCs from the 25 patients with SAP were markedly upregulated compared with the other groups, whereas no significant difference between the MAP group and healthy controls was observed. hfgl2 expression in the PBMCs and pancreatic tissues was detectable through using immunohistochemistry and was demonstrated to be speciﬁcally localized to the endothelium of microvessels and inflammatory infiltrative cells in the areas of acute focal, confluent necrosis. There were positive correlations between hfgl2 expression in the PBMCs and the severity of SAP, as indicated by scores of Ranson and Acute Physiology and Chronic Health Evaluation II. The results suggest that hfgl2 is involved in the pathogenesis of SAP and hfgl2 levels may serve as a biomarker during disease progression.

View Figures

View References

1	Lisman T and Porte RJ: Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost. 36:437–443. 2010. View Article : Google Scholar : PubMed/NCBI
2	Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T and Noguchi T: Antithrombin III prevents cerulein-induced acute pancreatitis in rats. Pancreas. 38:746–751. 2009. View Article : Google Scholar : PubMed/NCBI
3	Kakafika A, Papadopoulos V, Mimidis K and Mikhailidis DP: Coagulation, platelets, and acute pancreatitis. Pancreas. 34:15–20. 2007. View Article : Google Scholar
4	Agarwal N and Pitchumoni CS: Acute pancreatitis: a multisystem disease. Gastroenterologist. 1:115–128. 1993.PubMed/NCBI
5	Yasuda T, Ueda T, Kamei K, et al: Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis. J Gastroenterol. 44:1071–1079. 2009. View Article : Google Scholar : PubMed/NCBI
6	Warzecha Z, Dembiński A, Ceranowicz P, et al: Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats. J Physiol Pharmacol. 58:303–319. 2007.
7	Andersson E, Axelsson J, Pedersen LC, Elm T and Andersson R: Treatment with anti-factor VIIa in acute pancreatitis in rats: blocking both coagulation and inflammation? Scand J Gastroenterol. 42:765–770. 2007. View Article : Google Scholar : PubMed/NCBI
8	Dobosz M, Mionskowska L, Hac S, Dobrowolski S, Dymecki D and Wajda Z: Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats. World J Gastroenterol. 10:2553–2556. 2004.PubMed/NCBI
9	Doolittle RF: The structure and evolution of vertebrate fibrinogen. Ann N Y Acad Sci. 408:13–27. 1983. View Article : Google Scholar : PubMed/NCBI
10	Liu M, Leibowitz JL, Clark DA, et al: Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3. Eur J Biochem. 270:2274–2286. 2003. View Article : Google Scholar : PubMed/NCBI
11	Levy GA, Liu M, Ding J, et al: Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol. 156:1217–1225. 2000. View Article : Google Scholar : PubMed/NCBI
12	Chan CW, Chan MW, Liu M, et al: Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol. 168:5170–5177. 2002. View Article : Google Scholar : PubMed/NCBI
13	Marsden PA, Ning Q, Fung LS, et al: The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest. 112:58–66. 2003. View Article : Google Scholar : PubMed/NCBI
14	Mendicino M, Liu M, Ghanekar A, et al: Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. Circulation. 112:248–256. 2005. View Article : Google Scholar : PubMed/NCBI
15	Ghanekar A, Mendicino M, Liu H, et al: Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol. 172:5693–5701. 2004. View Article : Google Scholar : PubMed/NCBI
16	Knackstedt MK, Zenclussen AC, Hertwig K, et al: Th1 cytokines and the prothrombinase fgl2 in stress-triggered and inflammatory abortion. Am J Reprod Immunol. 49:210–220. 2003. View Article : Google Scholar : PubMed/NCBI
17	Clark DA, Foerster K, Fung L, et al: The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. Mol Hum Reprod. 10:99–108. 2004. View Article : Google Scholar : PubMed/NCBI
18	Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 128:586–590. 1993. View Article : Google Scholar : PubMed/NCBI
19	Zhang XP, Zhang J, Ma ML, et al: Pathological changes at early stage of multiple organ injury in a rat model of severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 9:83–87. 2010.PubMed/NCBI
20	Levitt S: Proprioceptive neuromuscular facilitation techniques in cerebral palsy. Physiotherapy. 52:46–51. 1966.PubMed/NCBI
21	Schwartz BS, Levy GA, Fair DS and Edgington TS: Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med. 155:1464–1479. 1982. View Article : Google Scholar
22	Su K, Chen F, Yan WM, et al: Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol. 14:5980–5989. 2008. View Article : Google Scholar : PubMed/NCBI
23	Liu M, Mendicino M, Ning Q, et al: Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol. 176:7028–7038. 2006. View Article : Google Scholar : PubMed/NCBI
24	Clark DA, Ding JW, Chaouat G, Coulam CB, August C and Levy GA: The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol. 42:37–43. 1999. View Article : Google Scholar : PubMed/NCBI
25	Clark DA, Chaouat G, Arck PC, Mittruecker HW and Levy GA: Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol. 160:545–549. 1998.
26	Clark DA, Ding JW, Yu G, Levy GA and Gorczynski RM: Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2. Mol Hum Reprod. 7:185–194. 2001. View Article : Google Scholar : PubMed/NCBI
27	Ning Q, Sun Y, Han M, et al: Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol. 174:7403–7411. 2005. View Article : Google Scholar : PubMed/NCBI
28	Li C, Fung LS, Chung S, et al: Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med. 176:689–697. 1992. View Article : Google Scholar : PubMed/NCBI
29	Gao S, Wang M, Ye H, et al: Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther. 21:969–977. 2010. View Article : Google Scholar : PubMed/NCBI
30	Zhu C, Sun Y, Luo X, Yan W, Xi D and Ning Q: Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther. 17:589–600. 2006. View Article : Google Scholar : PubMed/NCBI